These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 23300844)

  • 21. S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.
    Chuang JC; Warner SL; Vollmer D; Vankayalapati H; Redkar S; Bearss DJ; Qiu X; Yoo CB; Jones PA
    Mol Cancer Ther; 2010 May; 9(5):1443-50. PubMed ID: 20442312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia.
    Lemaire M; Momparler LF; Bernstein ML; Marquez VE; Momparler RL
    Anticancer Drugs; 2005 Mar; 16(3):301-8. PubMed ID: 15711182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-aza-2'-deoxycytidine-induced genome rearrangements are mediated by DNMT1.
    Maslov AY; Lee M; Gundry M; Gravina S; Strogonova N; Tazearslan C; Bendebury A; Suh Y; Vijg J
    Oncogene; 2012 Dec; 31(50):5172-9. PubMed ID: 22349820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia.
    Fabiani E; Leone G; Giachelia M; D'alo' F; Greco M; Criscuolo M; Guidi F; Rutella S; Hohaus S; Voso MT
    Leuk Lymphoma; 2010 Dec; 51(12):2275-84. PubMed ID: 21077739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.
    Hollenbach PW; Nguyen AN; Brady H; Williams M; Ning Y; Richard N; Krushel L; Aukerman SL; Heise C; MacBeth KJ
    PLoS One; 2010 Feb; 5(2):e9001. PubMed ID: 20126405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic mechanisms of irinotecan sensitivity in colorectal cancer cell lines.
    Crea F; Giovannetti E; Cortesi F; Mey V; Nannizzi S; Gallegos Ruiz MI; Ricciardi S; Del Tacca M; Peters GJ; Danesi R
    Mol Cancer Ther; 2009 Jul; 8(7):1964-73. PubMed ID: 19531575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Aza-2'-deoxycytidine increases the sensitivity of human bone marrow mesenchymal stem cells to chemotherapeutic agents by demethylation of p73.
    Liang W; Xia H; Li J; Chunhua Zhao R
    J Pediatr Hematol Oncol; 2012 Mar; 34(2):108-15. PubMed ID: 22278203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
    Höglund A; Nilsson LM; Forshell LP; Maclean KH; Nilsson JA
    Blood; 2009 Apr; 113(18):4281-8. PubMed ID: 19179467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
    Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
    Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
    Mossman D; Kim KT; Scott RJ
    BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
    Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA demethylation and invasive cancer: implications for therapeutics.
    Cheishvili D; Boureau L; Szyf M
    Br J Pharmacol; 2015 Jun; 172(11):2705-15. PubMed ID: 25134627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.
    Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N
    Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription factors Sp1 and p73 control the expression of the proapoptotic protein NOXA in the response of testicular embryonal carcinoma cells to cisplatin.
    Grande L; Bretones G; Rosa-Garrido M; Garrido-Martin EM; Hernandez T; Fraile S; Botella L; de Alava E; Vidal A; Garcia del Muro X; Villanueva A; Delgado MD; Fernandez-Luna JL
    J Biol Chem; 2012 Aug; 287(32):26495-505. PubMed ID: 22718761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
    Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
    Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kank1 reexpression induced by 5-Aza-2'-deoxycytidine suppresses nasopharyngeal carcinoma cell proliferation and promotes apoptosis.
    Luo FY; Xiao S; Liu ZH; Zhang PF; Xiao ZQ; Tang CE
    Int J Clin Exp Pathol; 2015; 8(2):1658-65. PubMed ID: 25973051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cells.
    Mao P; Hever MP; Niemaszyk LM; Haghkerdar JM; Yanco EG; Desai D; Beyrouthy MJ; Kerley-Hamilton JS; Freemantle SJ; Spinella MJ
    J Biol Chem; 2011 Jun; 286(22):19381-91. PubMed ID: 21489989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
    Shen WJ; Dai DQ; Teng Y; Liu HB
    World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microarray analysis of gene expression in metastatic gastric cancer cells after incubation with the methylation inhibitor 5-aza-2'-deoxycytidine.
    Chen J; Röcken C; Klein-Hitpass L; Götze T; Leodolter A; Malfertheiner P; Ebert MP
    Clin Exp Metastasis; 2004; 21(5):389-97. PubMed ID: 15672863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.